
Med Student Races to Cure ALS Before Her Own Clock Runs Out
At 32, Yentli Soto Albrecht has a 95% chance of developing the same fatal disease that killed her father. She's managing 11 research projects to find a cure in time.
Find uplifting stories about heroes, innovations, and solutions
27 results for "als research"

At 32, Yentli Soto Albrecht has a 95% chance of developing the same fatal disease that killed her father. She's managing 11 research projects to find a cure in time.

A medical student who inherited the genetic mutation that killed her father is now leading eleven research projects to cure ALS before it affects her. Yentli Soto Albrecht has a 95% chance of developing the fatal disease, but she's turning her fate into fuel for breakthrough research.

When Tim Evans was diagnosed with ALS on Valentine's Day 2014, he faced a choice: wait at home or use his remaining years to help others. He became the first volunteer in a Johns Hopkins study designed to improve quality of life for ALS patients.

A man with ALS chose purpose over despair, becoming the first volunteer in a Johns Hopkins study aimed at improving quality of life for patients. His decision turned a terminal diagnosis into a legacy of hope.

A man diagnosed with ALS on Valentine's Day 2014 chose to become the first volunteer in a Johns Hopkins study aimed at improving quality of life for others with the disease. Instead of waiting at home, Tim Evans is dedicating his remaining time to advancing research that could help thousands.

Tim Evans, diagnosed with ALS in 2014, chose to become the first volunteer in groundbreaking research at Johns Hopkins Medicine instead of letting his disease define his final chapter. His decision could help improve quality of life for thousands of ALS patients diagnosed each year.
Jeff Vierstra lost his mother and two sisters to a deadly genetic disease, but an experimental treatment may be preventing him from developing ALS for the first time in his family's history. After three years of spinal infusions targeting his mutated gene, the 41-year-old shows no signs of the disease.

A promising ALS treatment has enrolled its first patient in a major clinical trial that could slow disease progression. The drug showed encouraging results in early-stage patients during previous testing.

A groundbreaking ALS treatment has enrolled its first patient in a major clinical trial that could help slow disease progression in early-stage patients. The study follows encouraging results showing the drug helped preserve speech and breathing function in rapid-decline patients.

The only multidisciplinary ALS clinic in the Mountain West now offers groundbreaking gene therapy for patients with genetic forms of the disease. University of Utah Health's team brings together 10+ specialists in one visit, making life easier for the 30,000 Americans living with ALS.

Researchers figured out why your shaving cream drips faster than physics says it should. The bubbles themselves rearrange to create escape routes for liquid.

Australian researchers discovered how to transform discarded peanut shells into high-quality graphene, the wonder material that powers modern technology. The breakthrough could solve two problems at once: reducing 10 million tons of annual waste while making graphene cheaper and greener to produce.
A protein known for causing ALS and dementia also controls DNA repair, opening new doors for treating both brain diseases and cancer. The discovery could reshape how doctors approach two of medicine's biggest challenges.

A University of Missouri researcher found a way to deliver healing molecules past the brain's protective barrier, improving ALS symptoms in mice. The breakthrough could lead to human trials that might one day prevent the disease before symptoms start.

Professional golfer Brooks Koepka is fulfilling his $5 million charitable commitment required for his return to the PGA Tour from LIV Golf. The donations are supporting causes from children's healthcare to accelerating ALS research.

Golf star Brooks Koepka is fulfilling his $5 million charity pledge as part of his return to the PGA Tour from LIV Golf. The money is going to causes that range from children's health to accelerating ALS research.

Golf star Brooks Koepka is fulfilling his $5 million charity pledge by supporting causes from children's healthcare to ALS research. Among the recipients is a foundation started by a 30-year industry veteran recently diagnosed with Lou Gehrig's disease.

Pro golfer Brooks Koepka is directing $5 million to children's hospitals, foundations, and fellow players' charities as part of his return to the PGA Tour. The donation includes $1 million to Nicklaus Children's Health Care Foundation and support for causes from ALS research to limb-difference advocacy. #

After decades of slow progress, ALS researchers at VCU Health say they're more optimistic about finding a cure than at any point in history. The Richmond team is combining new FDA-approved treatments with cutting-edge research to extend lives and find solutions.

The U.S. just approved the largest federal ALS research budget in history at $315 million. New treatments targeting the disease's root causes are showing real promise for the first time.
Showing 20 of 27